Affiliation:
1. Bukovinian State Medical University
Abstract
The article considers the literature on the role of the renin-angiotensin system in the mechanisms of coronavirus disease development, biochemical properties and mechanisms of dalargin as a synthetic representative of the group of endogenous opioids, its potential to modulate the renin-angiotensin system of the human body. Conclusions are made on the theoretical possibility of using the medicine in complex therapy in the treatment of coronavirus disease.
Publisher
European Scientific Platform Publishing
Reference22 articles.
1. WHO. (n.d.). COVID 19 Experimental Treatments. WHO | World Health Organization. https://www.who.int/docs/default-source/coronaviruse/covid-classification-of-treatment-types-rev.pdf?sfvrsn=5b90b2f2_1&download=true.
2. Endogenous opioid systems: current concepts and clinical correlations. Eduardo E. Benarroch. First published August 20, 2012, DOI: https://doi.org/10.1212/WNL.0b013e3182662098.
3. Santiago, T. V., & Edelman, N. H. (1985). Opioids and breathing. Journal of applied physiology (Bethesda, Md.:1985), 59(6), 1675–1685. https://doi.org/10.1152/jappl.1985.59.6.1675.
4. An Open Randomized Study of Dalargin Effectiveness in Patients with Severe and Critical Manifestations of SARS-COVID-19. Retrieved from: https://clinicaltrials.gov/ct2/show/study/NCT04346693.
5. Yan, R., Zhang, Y., Li, Y., Xia, L., Guo, Y., & Zhou, Q. (2020). Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science (New York, N.Y.), 367(6485), 1444–1448. https://doi.org/10.1126/science.abb2762.